Smith Isabelle L, Brown Sarah, McGinnis Elizabeth, Briggs Michelle, Coleman Susanne, Dealey Carol, Muir Delia, Nelson E Andrea, Stevenson Rebecca, Stubbs Nikki, Wilson Lyn, Brown Julia M, Nixon Jane
Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
Leeds Teaching Hospitals NHS Trust, Leeds, UK.
BMJ Open. 2017 Jan 20;7(1):e013623. doi: 10.1136/bmjopen-2016-013623.
To explore pressure area related pain as a predictor of category ≥2 pressure ulcer (PU) development.
Multicentre prospective cohort study.
UK hospital and community settings.
Consenting acutely ill patients aged ≥18 years, defined as high risk (Braden bedfast/chairfast AND completely immobile/very limited mobility; pressure area related pain or; category 1 PU).
Patients too unwell, unable to report pain, 2 or more category ≥2 PUs.
FOLLOW-UP: Twice weekly for 30 days.
Development and time to development of one or more category ≥2 PUs.
Of 3819 screened, 1266 were eligible, 634 patients were recruited, 32 lost to follow-up, providing a 602 analysis population. 152 (25.2%) developed one or more category ≥2 PUs. 464 (77.1%) patients reported pressure area related pain on a healthy, altered or category 1 skin site of whom 130 (28.0%) developed a category ≥2 PU compared with 22 (15.9%) of those without pain. Full stepwise variable selection was used throughout the analyses. (1) Multivariable logistic regression model to assess 9 a priori factors: presence of category 1 PU (OR=3.25, 95% CI (2.17 to 4.86), p<0.0001), alterations to intact skin (OR=1.98, 95% CI (1.30 to 3.00), p=0.0014), pressure area related pain (OR=1.56, 95% CI (0.93 to 2.63), p=0.0931). (2) Multivariable logistic regression model to account for overdispersion: presence of category 1 PU (OR=3.20, 95% CI (2.11 to 4.85), p<0.0001), alterations to intact skin (OR=1.90, 95% CI (1.24 to 2.91), p=0.0032), pressure area related pain (OR=1.85, 95% CI (1.07 to 3.20), p=0.0271), pre-existing category 2 PU (OR=2.09, 95% CI (1.35 to 3.23), p=0.0009), presence of chronic wound (OR=1.66, 95% CI (1.06 to 2.62), p=0.0277), Braden activity (p=0.0476). (3) Accelerated failure time model: presence of category 1 PU (AF=2.32, 95% CI (1.73 to 3.12), p<0.0001), pressure area related pain (AF=2.28, 95% CI (1.59 to 3.27), p<0.0001). (4) 2-level random-intercept logistic regression model: skin status which comprised 2 levels (versus healthy skin); alterations to intact skin (OR=4.65, 95% CI (3.01 to 7.18), p<0.0001), presence of category 1 PU (OR=17.30, 95% CI (11.09 to 27.00), p<0.0001) and pressure area related pain (OR=2.25, 95% CI (1.53 to 3.29), p<0.0001).
This is the first study to assess pain as a predictor of category ≥2 PU development. In all 4 models, pain emerged as a risk factor associated with an increased probability of category ≥2 PU development.
探讨与压力区域相关的疼痛作为≥2期压疮(PU)发生的预测指标。
多中心前瞻性队列研究。
英国医院及社区环境。
年龄≥18岁的急性病患者,同意参与研究,定义为高危患者(Braden评分提示卧床/坐椅受限且完全不能活动/活动非常受限;与压力区域相关的疼痛或;1期PU)。
病情过重、无法报告疼痛、有2处或更多处≥2期PU的患者。
为期30天,每周随访两次。
一处或多处≥2期PU的发生情况及发生时间。
在3819例筛查对象中,1266例符合条件,634例患者被招募,32例失访,最终有602例纳入分析。152例(25.2%)发生一处或多处≥2期PU。464例(77.1%)患者在健康、皮肤改变或1期皮肤部位报告有与压力区域相关的疼痛,其中130例(28.0%)发生≥2期PU,而无痛患者中发生≥2期PU的有22例(15.9%)。在整个分析过程中采用了全逐步变量选择法。(1)多变量逻辑回归模型评估9个先验因素:1期PU的存在(比值比[OR]=3.25,95%置信区间[CI](2.17至4.86),p<0.0001),完整皮肤的改变(OR=1.98,95%CI(1.30至3.00),p=0.0014),与压力区域相关的疼痛(OR=1.56,95%CI(0.93至2.63),p=0.0931)。(2)多变量逻辑回归模型以处理过度离散问题:1期PU的存在(OR=3.20,95%CI(2.11至4.85),p<0.0001),完整皮肤的改变(OR=1.90,95%CI(1.24至2.91),p=0.0032),与压力区域相关的疼痛(OR=1.85,95%CI(1.07至3.20),p=0.0271),既往2期PU(OR=2.09,95%CI(1.35至3.23),p=0.0009),慢性伤口的存在(OR=1.66,95%CI(1.06至2.62),p=0.0277),Braden活动评分(p=0.0476)。(3)加速失效时间模型:1期PU的存在(加速因子[AF]=2.32,95%CI(1.73至3.12),p<0.0001),与压力区域相关的疼痛(AF=2.28,95%CI(1.59至3.27),p<0.0001)。(4)二级随机截距逻辑回归模型:皮肤状态分为2级(与健康皮肤相比);完整皮肤的改变(OR=4.65,95%CI(3.01至7.18),p<0.0001),1期PU的存在(OR=17.30,95%CI(11.09至27.00),p<0.0001)以及与压力区域相关的疼痛(OR=2.25,95%CI(1.53至3.29),p<0.0001)。
这是第一项评估疼痛作为≥2期PU发生预测指标的研究。在所有4个模型中,疼痛均作为与≥2期PU发生概率增加相关的危险因素出现。